Ocular Effects of Niacin: A Review of the Literature
- PMID: 26060832
- PMCID: PMC4458328
Ocular Effects of Niacin: A Review of the Literature
Abstract
Cystoid macular edema is a condition that involves the macula, caused by an accumulation of extracellular fluid in the macular region with secondary formation of multiple cystic spaces. This condition is provoked by a variety of pathological conditions such as intraocular inflammation, central or branch retinal vein occlusion, diabetic retinopathy and most commonly following cataract extraction, hereditary retinal dystrophies, and topical or systemic assumption of drugs. Niacin is a vitamin preparation usually used for the treatment of lipid disorders. The treatment with niacin, alone or in combination with other lipid-lowering agents, significantly reduces total mortality and coronary events and slows down the progression of and induces the regression of coronary atherosclerosis. Several cases of niacin-induced cystoid macular edema have been reported with different dosages.
Keywords: Cystoid Macular Edema; Niacin Maculopathy; Nicotinic Acid; Side Effects.
Figures
Similar articles
-
Cystoid macular edema induced by low doses of nicotinic Acid.Case Rep Ophthalmol Med. 2013;2013:713061. doi: 10.1155/2013/713061. Epub 2013 Apr 11. Case Rep Ophthalmol Med. 2013. PMID: 23662229 Free PMC article.
-
Cystoid macular edema.Optom Clin. 1996;5(1):111-30. Optom Clin. 1996. PMID: 8963073 Review.
-
Blood levels in macular cystoid spaces and their relationship to retinal vein obstruction.Retina. 1994;14(1):14-8. doi: 10.1097/00006982-199401000-00004. Retina. 1994. PMID: 8016455
-
Fluid blood level in cystoid space resulting from central retinal vein occlusion.J Am Optom Assoc. 1998 Feb;69(2):129-32. J Am Optom Assoc. 1998. PMID: 9549262
-
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.Doc Ophthalmol. 1999;97(3-4):297-309. doi: 10.1023/a:1002130005227. Doc Ophthalmol. 1999. PMID: 10896343 Review.
Cited by
-
[Niacin-associated macular edema after consumption of dietary supplements].Ophthalmologie. 2024 Mar;121(3):223-226. doi: 10.1007/s00347-023-01937-y. Epub 2023 Oct 11. Ophthalmologie. 2024. PMID: 37819606 German. No abstract available.
-
Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies.Life (Basel). 2023 Apr 30;13(5):1120. doi: 10.3390/life13051120. Life (Basel). 2023. PMID: 37240765 Free PMC article. Review.
-
Adverse Ocular Effects of Systemic Medications.Life (Basel). 2023 Feb 28;13(3):660. doi: 10.3390/life13030660. Life (Basel). 2023. PMID: 36983816 Free PMC article. Review.
-
Severity of cystoid macular oedema in preterm infants observed using hand-held spectral domain optical coherence tomography improves weekly with postmenstrual age.Eye (Lond). 2023 Oct;37(14):3009-3014. doi: 10.1038/s41433-023-02461-8. Epub 2023 Mar 16. Eye (Lond). 2023. PMID: 36928228 Free PMC article.
-
Niacinamide and Neuroprotection: The Glaucoma Holy Grail.J Curr Glaucoma Pract. 2022 Sep-Dec;16(3):141-143. doi: 10.5005/jp-journals-10078-1390. J Curr Glaucoma Pract. 2022. PMID: 36793265 Free PMC article.
References
-
- Kanski JJ. Oftalmologia clinica. Masson: Elsevier; 2008. pp. 650–53.
-
- Millay RH, Klein KL, Illingsworth DR. Niacin maculopathy. Ophthalmology. 1988 Jul;95(7):930–6. PMID: 3174043. - PubMed
-
- Callanan D, Blodi BA, Martin DF. Macular edema associated with nicotinic acid (niacin) [letter] JAMA. 1998 Jun ;279(21) PMID: 9624021. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources